This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Similarly, the EMA’s 2024 report on RWE framework focuses on harmonizing data standards, outlining regulatory science strategies, and promoting collaborations to integrate RWD into regulatory decisions effectively. and European regulators.
What You Should Know: – Caris LifeSciences (Caris) , a pioneer in precision medicine and next-generation AI TechBio innovation, announced a transformative collaboration with Ontada , a leading organization in oncology real-world evidence, clinical education, and point-of-care technologies.
Somai knows AI, and strongly believes it is an integral part of the healthcare ecosystem and poised to bring about powerful, transformative change to the industry. By integrating genAI into the fabric of healthcare, we stand really on the brink of a new frontier in medicine and lifesciences.
Nole , as she shares her progression from first-generation college graduate to Corporate Vice President of Microsoft Health & LifeSciences and General Manager of the Nuance Healthcare Division. Join me for a great discussion with Diana L.
What You Should Know: – ConcertAI, LLC (ConcertAI), the leader in enterprise AI and real-world data (RWD) solutions for lifesciences and healthcare, announced the close of its $150M in Series C led by Sixth Street at a $1.9B Accelerating Enterprise SaaS AI from Clinical Research to ClinicalPractice.
Brian Williams, LifeSciences Strategy & Innovation at EPAM Systems, Inc. Although the traditional nearly decade-long clinical trial timelines completely collapsed during COVID, this truncating was not necessarily novel.
Christopher Wooden, Senior Director, Business Marketing, IQVIA A critical aspect of any pharma/lifesciences commercialization strategy is to develop and deploy effective and meaningful ways to engage, inform and build trust with healthcare providers (HCPs).
What You Should Know: ArteraAI , a leader in artificial intelligence (AI)-powered cancer tests, today announced a significant achievement – the inclusion of their ArteraAI Prostate Test in the NCCN ClinicalPractice Guidelines in Oncology (NCCN Guidelines®) for Prostate Cancer.
Syntropy’s product development team leader, Michael Vande-Vrede answered my questions about what it all means in practice. What are the key data quality challenges in clinical research and clinicalpractice? Collectively, we cover the complete spectrum of the data lifecycle, enhancing data integrity at every phase.
Racism in R&D/Clinicalpractices: Lack of representation of people of color (POC) among both patients and physicians, barriers to access and other obstacles like bias, lack of trust and fear, and limited care access all limit the quality of health and research outcomes among affected groups. SCAN Health Plan) 4.
Over the past 15 years, we’ve seen an explosion of targeted therapies including small molecules, immunotherapies, cell-based treatments, and more all made possible by the integration of large-scale ‘omics data with clinical insights, treatment approaches, and patient outcomes.
We organize all of the trending information in your field so you don't have to. Join 19,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content